Skip to main content
Hassan El Chebib, MD, Pediatric Infectious Disease, Hartford, CT, Connecticut Children's Medical Center

HassanEl ChebibMDFAAP

Pediatric Infectious Disease • Hartford, CT

Attending Physician At Connecticut Children's; Associate Professor at University of Connecticut School of Medicine; Program Director of the pediatric infectious disease fellowship program at University of Connecticut

Join to view full profile

Dr. El Chebib is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. El Chebib's full profile

Already have an account?

Summary

  • Pediatric Infectious Disease specialist with experience in immunology and demonstrated history of working in the hospital & health care industry. Skilled in Epidemiology, Molecular Biology, Cell Culture, Healthcare, and Clinical Research. Strong healthcare services professional with a M.D. focused in Medicine from American University of Beirut.

Education & Training

  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityChief Residency, Pediatrics, 2019 - 2019
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityResidency, Pediatrics, 2017 - 2019
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityFellowship, Pediatric Infectious Diseases, 2014 - 2017
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2007
  • American University of Beirut
    American University of BeirutBS, Biology, 1998 - 2002

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2019 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases
  • American Board of PediatricsPediatric Infectious Diseases
  • Collaborative Institutional Training Initiative ProgramCITI Program Certification
  • ECFMGECFMG certificate

Awards, Honors, & Recognition

  • Star of the week Connecticut Children's Medical Center Executive Team, 2020
  • Infectious diseases society of America Antimicrobial Stewardship Center of Excellence Designation Infectious Diseases Society of America, 2020
  • Didactic teaching award Connecticut Children's, 2020
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Neutrophil activation in infants hospitalized with severe respiratory viral infections.
    El Chebib, H., Bonville, CA, Domachowske, JB and Suryadevara, M., Pediatric Research Day, Syracuse, NY, 4/2017
  • Neutrophil activation in infants hospitalized with severe respiratory viral infections.
    El Chebib, H., Bonville, CA., Domachowske, JB., & Suryadevara, M., Annual joint meeting of the Infectious Disease Society of America, Society for Healthcare Epidemiology of America, the HIV Medical Association and the Pediatric Infectious Diseases Society during the ID week, New Orleans, LA, 10/2016
  • Neutrophil activation in infants hospitalized with severe respiratory viral infections
    • El Chebib, H., Bonville, CA , Domachowske, JB and Suryadevara, M., Open Forum Infectious Diseases, 2016
  • Join now to see all

Lectures

  • HIV: A Pediatric Perspective 
    University of Connecticut - 11/2021
  • Immune Deficiencies in Children - Case Review 
    Connecticut Children's - 10/2021
  • Sexually Transmitted Infections 
    VBMC - 10/2021
  • Join now to see all

Press Mentions

  • Work of Postdoctoral Students, Fellows and Medical Residents Spotlighted on Research Day March 1
    Work of Postdoctoral Students, Fellows and Medical Residents Spotlighted on Research Day March 1November 22nd, 2011
  • Doctor Says Fight is Not Finished on Measle Vaccination
    Doctor Says Fight is Not Finished on Measle VaccinationSeptember 8th, 2020
  • Ask the Experts
    Ask the ExpertsSeptember 8th, 2020
  • Join now to see all

Committees

  • Infectious disease physician member, COVID-19 Vaccine Task Force 2021 - Present
  • Pediatric infectious disease physician member, Combined adult and pediatric infectious disease committee 2021 - Present
  • Infectious disease physician member, Multisystem Inflammatory Syndrome in Children Task Force 2020 - Present
  • Infectious disease physician member, Educational Leadership Committee 2020 - Present
  • Infectious disease physician member, Clinical Effectiveness Committee 2020 - Present
  • Infectious disease physician member, Antimicrobial stewardship in the neonatal intensive care unit work group 2020 - Present
  • Infectious disease physician member, Antimicrobial stewardship committee 2020 - Present
  • Infectious disease physician member, Pediatric infectious disease outpatient committee on improving healthcare delivery 2020 - Present
  • Infectious disease physician member, Clinical pathway improvement committee 2020 - Present
  • Infectious disease physician member, Pediatric pharmacy and therapeutic committee 2020 - Present
  • Infectious disease physician member, Coronavirus disease-19 guideline task force 2020 - Present
  • Infectious disease physician member, Coronavirus disease-19 Connecticut Children's employee infection control, testing and return to work task force 2020 - Present
  • Associate director, Pediatric infectious disease fellowship program evaluation committee 2020 - Present
  • Infectious disease physician member, Clinical Competency Committee 2020 - Present
  • Associate program director, Fellowship Program Directors Committee 2020 - Present
  • Infectious disease physician member, Pediatric pharmacy residency selection committee 2020 - 2020
  • Infectious disease physician member, Cytomegalovirus prevention and treatment guidelines for solid organ pediatric transplant in clinical practice 2020 - 2020
  • Pediatric infectious disease member, Pediatric subcommittee of pharmaceutical and therapeutics committee 2016 - 2017
  • Pediatric infectious disease member, Pediatric infection control committee 2016 - 2017
  • Pediatric infectious disease member, Influenza immunization rates improvement in hospitalized pediatric patients 2016 - 2017
  • Project leader, Hepatitis B vaccination rates improvement in pediatric patients with HIV 2015 - 2017
  • Project leader, Solid organ pre-transplant workup protocol in the donor and recipient patients 2015 - 2017
  • Pediatric infectoius disease member, Pediatric antimicrobial stewardship committee 2014 - 2019
  • Pediatric infectious disease member, Pediatric central line associated blood stream infections quality improvement committee 2014 - 2017
  • Pediatric member and representative, Lebanese Order of Physicians’ Pediatric committee for improving residency programs 2011 - 2014

Research History

  • Co-investigatorIdentifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)2021 - Present
  • Co-investigatorPatients Under Investigation for Coronavirus Disease 2019 (PUI) Repository2020 - Present
  • Co-investigatorA multi-center study to describe the epidemiology, clinical presentation, and outcomes of pediatric patients with COVID-19 across the United States2020 - Present
  • Primary investigatorSafety and immunogenicity study of VLA15, a multivalent recombinant OSPA based vaccine candidate against Lyme Borreliosis: a randomized, controlled, observer-blind phase 2 study in a healthy pediatric and adult study population2021 - 2021
  • Co-investigatorExpanded Access IND Program to Provide Stamaril Vaccine to Persons in the United States for Vaccination Against Yellow Fever2020 - 2021
  • Sub-investigatorA phase 3, multicenter, open-label, randomized, comparator controlled trial of the safety and efficacy of dalbavancin versus active comparator in pediatric subjects with acute bacterial skin and skin structure infections. Sponsor: Allergan.2017 - 2017
  • Sub-investigatorClinical Performance of the Diassess Influenza A and B Test. Sponsor: Diassess.2017 - 2017
  • Sub-investigatorA Prospective Study to Assess the Pediatric Respiratory Syncytial Virus (RSV) Electronic Severity and Outcome Rating System (PRESORS) and Clinical Endpoints in Neonates, Infants, and Children less than or equal to 36 Months of Age Hospitalized with RSV Infection. Sponsor: Janssen.2017 - 2017
  • Sub-investigatorA Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13TM in Healthy Infants. Sponsor: Merck.2017 - 2017
  • Sub-investigatorA Phase 3, Randomized, Observer-Blind, Placebo- Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a RSV F Nanoparticle Vaccine with Aluminum in Healthy Third-Trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies. Sponsor: GSK2016 - 2017
  • Sub-investigatorA Phase 1/2, randomized, observer-blind, controlled, multi- center, dose-escalation study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on the RSV viral proteins encoded by chimpanzee derived adenovector. Sponsor: Glaxosmithkline2016 - 2017
  • Co-investigatorA single-center in vitro study to evaluate the level of expression of CD11b in neutrophils of children less than 2 years of age with viral respiratory tract infections. Partial sponsors: GlaxoSmithKline and Clark Foundation as part of State University of New York Upstate Medical University Hospital.2015 - 2017
  • Sub-investigatorA retrospective and prospective chart review of disease markers and treatment measures in pediatric Hepatitis A, B and C patients to identify consistent disease parameters for use in clinical management. Sponsor: Intramural as part of State University of New York Medical University Hospital.2014 - 2017
  • Sub-investigatorA phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a human monoclonal antibody, REGN2222, for the prevention of medically attended RSV infection in preterm infants. Sponsor: Regeneron.2015 - 2016
  • Sub-investigatorA phase 1b/2a randomized, double-blind, placebo- controlled, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of MEDI8897, a monoclonal antibody with an extended half-life against respiratory syncytial virus, in healthy preterm infants. Sponsor: Medimmune.2014 - 2016
  • Sub-investigatorA phase III, obersver-blind, randomized, controlled, multi-center study to evaluate the immunogenicity and safety of GSK biologicals’ quadrivalent influenza vaccine candidate compared to Sanofi Pasteur’s quadrivalent influenza vaccine Fluzone quadrivalent, administered intramuscularly. Sponsor: GSK2014 - 2015
  • Research fellowGalactosyl ceramide supplementation of CLN3 knock down mice. Sponsor: Dubai Harvard Foundation for Medical Research.2008 - 2011

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations

External Links

  • LinkedInhttps://www.linkedin.com/in/hassan-el-chebib-md-faap-b3959a2b/

Dr. Hassan El Chebib, Dr. Hassan El Chebib, MD, Dr. H El Chebib